AU2002351795A1 - Hepatitis x virus antigen - Google Patents

Hepatitis x virus antigen

Info

Publication number
AU2002351795A1
AU2002351795A1 AU2002351795A AU2002351795A AU2002351795A1 AU 2002351795 A1 AU2002351795 A1 AU 2002351795A1 AU 2002351795 A AU2002351795 A AU 2002351795A AU 2002351795 A AU2002351795 A AU 2002351795A AU 2002351795 A1 AU2002351795 A1 AU 2002351795A1
Authority
AU
Australia
Prior art keywords
hepatitis
virus antigen
antigen
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002351795A
Inventor
Terukatsu Arima
Kazuaki Ishibashi
Hong Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU2002351795A1 publication Critical patent/AU2002351795A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AU2002351795A 2002-10-28 2002-10-28 Hepatitis x virus antigen Abandoned AU2002351795A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2002/012026 WO2004038028A2 (en) 2002-10-28 2002-10-28 Hepatitis x virus antigen

Publications (1)

Publication Number Publication Date
AU2002351795A1 true AU2002351795A1 (en) 2004-05-13

Family

ID=32116211

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002351795A Abandoned AU2002351795A1 (en) 2002-10-28 2002-10-28 Hepatitis x virus antigen

Country Status (2)

Country Link
AU (1) AU2002351795A1 (en)
WO (1) WO2004038028A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2003068973A1 (en) * 2002-02-13 2005-06-02 暉勝 有馬 DNA sequences and encoded polypeptides useful for the diagnosis of hepatitis

Also Published As

Publication number Publication date
WO2004038028A2 (en) 2004-05-06

Similar Documents

Publication Publication Date Title
HK1070287A1 (en) Hepatitis c virus inhibitors
AU2002210450A1 (en) Maintaining virus detection software
GB0206360D0 (en) Viral antigens
GB0206359D0 (en) Viral antigens
EP1684787A4 (en) Hepatitis c virus inhibitors
EP1684745A4 (en) Hepatitis c virus inhibitors
AU2001282528A1 (en) Compounds having anti-hepatitis c virus effect
AU2002256895A1 (en) Anti-TRAIL-R antibodies
AU2003206862A1 (en) Hepatitis b vaccines
AUPQ912000A0 (en) Improved virus like particles
AU2003294757A1 (en) Formulations useful against hepatitis c virus infections
AU2003301850A1 (en) Hiv vaccine
AU2002257890A1 (en) Method for replicating the hepatitis C virus
AU2003301865A1 (en) Epitopes of hepatitis c virus
AU2003256404A1 (en) Hepatitis c virus assays
AU2003227026A1 (en) An infectious bursal disease virus variant
AU2003248821A1 (en) Chimeric gb virus b (gbv-b)
AU2003230790A1 (en) Hepatitis c virus sub-genomic replicons
AU2002351795A1 (en) Hepatitis x virus antigen
AU2003221569A1 (en) Cd4+ t-lymphocyte-specific hepatitis c virus epitopes
AU2003237701A1 (en) Vaccines
AU2003289016A1 (en) Method of distinguishing drug-resistance of hepatitis b virus
AU2003225479A1 (en) Reporter-selectable hepatitis c virus replicon
AU2003263028A1 (en) Mouse hepatitis virus detection
AU2003214299A1 (en) Hiv-1 virus tat-protein mutants

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase